SCHEMBL7361372

SCHEMBL7361372

CCOC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)c1cccnc1Nc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACE P12821 5/20 0.45
LMNA P02545 1/20 0.45
KCNK3 O14649 1/20 0.45
PREP P48147 5/20 0.43
FAP Q12884 3/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
RAB9A P51151 2/20 0.41
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
DHODH Q02127 1/20 0.40
NPC1 O15118 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
P2RY12 Q9H244 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8476331 0.85 MAPK8 (0.52) ACELMNAKCNK3PREPFAP
SCHEMBL7369918 0.85 MAPK8 (0.52) ACELMNAKCNK3PREPFAP
SCHEMBL7363975 0.85 CYP2C19 (0.52) ACELMNAKCNK3PREPFAP
SCHEMBL7364635 0.84 ALDH1A1 (0.47) ACELMNAKCNK3PREPFAP
SCHEMBL7368109 0.83 PREP (0.43) ACELMNAKCNK3PREPFAP
SCHEMBL7366700 0.78 ACE (0.50) ACELMNAPREPFAPALDH1A1
SCHEMBL8720975 0.77 ACE (0.45) ACELMNAKCNK3PREPFAP
SCHEMBL7369394 0.77 SMYD3 (0.50) ACELMNAKCNK3PREPFAP
SCHEMBL7368017 0.76 ACE (0.47) ACELMNAKCNK3PREPFAP
SCHEMBL7366766 0.74 PREP (0.66) ACELMNAKCNK3PREPFAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0500989-B1 N-(alpha-substituted-pyridinyl) carbonyl dipeptide antihypertensive agents LACER SA (ES) 1998-12-09 EP disclosed
US-5432159-A N-(α-substituted-pyridinyl)carbonyl dipeptide antihypertensive agents LACER S.A. (ES) 1995-07-11 US disclosed
WO-1992015608-A1 N-(α-SUBSTITUTED-PYRIDINYL)CARBONYL DIPEPTIDE ANTIHYPERTENSIVE AGENTS LACER S.A. (ES) 1992-09-17 WO disclosed
EP-0500989-A1 N-(alpha-substituted-pyridinyl) carbonyl dipeptide antihypertensive agents LACER, S.A. (ES) 1992-09-02 EP disclosed